Ablation is removal of biological material from human organs by vaporization, cryotreatment, radiation procedures, chipping, or other erosive processes. In medical sector, ablation is performed usually through surgical methods for the removal of biological substances i.e., usually a small tumor. Other techniques adopted for the removal of infected biological tissues include chemical ablation and radiofrequency ablation.
Request Free PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/464
In the recent past, ablation has received immense popularity, owing to its minimally invasive nature of removal of tumors and tissues with bearable pain less recovery period than that of open surgical procedures. Demand for ablation devices is expected to increase owing to increasing incidence of chronic diseases, mainly tumorigenic cancer and other cardiovascular disorders, across the globe. According to the World Health Organization, chronic diseases are major causes of mortality, leading to 38 million deaths worldwide in 2015. Moreover, according to the same source, cancer is one of the leading causes of death that accounted for up to 8.8 million deaths in 2015. According to Centers of Disease Control and Prevention (CDC), in 2016, around 2.7-6.1 million people in the U.S. suffered from atrial fibrillation. Moreover, according to the same source, around 2% of people aged 65 years and below are affected with atrial fibrillation. High prevalence of such diseases will in turn, boost the growth of global ablation devices market.
The global ablation devices market was valued at US$ 3,330.0 million in 2016 and is expected to witness a CAGR of 10.9% during the forecast period (2017 – 2025).
High prevalence of cardiovascular disorders is expected to drive the global ablation devices market
Growing incidence of cardiovascular disorders, increasing geriatric population, growing awareness of the benefits of ablation devices, and development of novel technology in healthcare sector is expected to drive growth of the global ablation devices market during the forecast period. Cardiovascular disorders such as, atrial fibrillation and arrhythmia, which are highly susceptible to open heart surgeries and can be treated with ablation at earlier stages.
Highs cost of treatment of ablation surgery and major side effects of surgical ablation procedures such as chemical allergies and strokes are expected to restrain growth of the global ablation devices market over the forecast period.
Among regions, North America holds the domain position in the global ablation devices market in terms of sales of ablation devices. This is owing to robust healthcare infrastructure and significant expenditure targeted on developing the healthcare facilities in the region. Moreover, increasing demand for minimally invasive surgical procedures, especially in the treatment of cardiac arrhythmia, is expected to drive the regional market growth in the near future.
Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/ablation-devices-market-464
Key players operating in the global ablation devices market are Arthrex, Baxter Inc., Boston Scientific Corporation, Medtronic, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Halyard Health, Abbott Laboratories, EDAP TMS S.A, AtriCure, Inc., and Smith & Nephew.
Key players involved in the strategic implementation of various policies for technological advancements and innovation of ablation devices are,
- In 2016, Medtronic expanded its pain therapies portfolio with the launch of OsteoCool RF ablation system. The company expanded its minimally invasive therapy portfolio with the acquisition of the gynecology business from Smith & Nephew.
- In 2015, EDAP TMS announced a multinational strategic OEM partnership with Quanta System, which is a leading manufacturer of medical lasers for surgical applications. Through this partnership, Quanta manufactures customized urological stone lasers to be sold under EDAP brand.
- In 2015, AtricCure, Inc. acquired nContact, Inc., a privately-held developer of innovative cardiac ablation solutions to provide improved market access to ablation devices.
- In 2016, Boston Scientific Corporation acquired Cosman Medical to get its hands on the company’s Radiofrequency Ablation (RFA) system, in order to expand its neuromodulation portfolio.
In 2013, Abbott Laboratories acquired IDEV Technologies, a privately-owned company focused on developing next-generation medical devices for use of ablation catheters in electrophysiology. The company also acquired two other catheter-based medical device companies, namely Advanced Cardiac Therapeutics, Inc. and Topera, Inc. to enter the electrophysiology ablation devices market.
Other Related Market Research Reports:
Cryoablation Devices Market, By Device Type, Application, End User and by Regions – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Cardiac Ablation Catheters Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Global Tumor Ablation Devices Market, by Technology, Application, End User, and Geography – Trends and Forecast to 2025
Name: Mr. Raj Shah
Phone: US +12067016702 / UK +4402081334027